|
|
chromatin organization
|
GO:0006325 |
206 |
0.568
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.207
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.194
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.184
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.156
|
Mouse |
|
|
rna splicing
|
GO:0008380 |
54 |
0.152
|
Mouse |
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.149
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.146
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.144
|
Mouse |
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.142
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.141
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.128
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.128
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.123
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.111
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.104
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.101
|
Mouse |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.099
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.096
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.094
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.088
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.087
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.085
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.084
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.082
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.080
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.079
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.077
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.076
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.076
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.074
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.073
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.072
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.072
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.070
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.069
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.067
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.066
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.066
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.065
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.064
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.063
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.062
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.059
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.058
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
0.055
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.054
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.053
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.053
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.053
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.052
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.052
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.051
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.051
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.051
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.050
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.049
|
Mouse |
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.047
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.047
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.047
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.047
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.046
|
Mouse |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.046
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.045
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.045
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.045
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.045
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.043
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.042
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.041
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.041
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.040
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.040
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.040
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.039
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.039
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.038
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.035
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.035
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.034
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.034
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.034
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.033
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.032
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.032
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.029
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.028
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.028
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.028
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.027
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.026
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.026
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.026
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.025
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.025
|
Mouse |
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.025
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.025
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.024
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.024
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.024
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.023
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.023
|
Mouse |
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.023
|
Mouse |
|
|
histone acetylation
|
GO:0016573 |
41 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.023
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.022
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.022
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.022
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.022
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.022
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.021
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.021
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.021
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.021
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.020
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.018
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.018
|
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.018
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.018
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.018
|
Mouse |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
Mouse |
|
|
regulation of dna damage checkpoint
|
GO:2000001 |
3 |
0.018
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.018
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.017
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.017
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.017
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.017
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.016
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.016
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.016
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.016
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.016
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.016
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.016
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.016
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.016
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.016
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.016
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.015
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.015
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.015
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.015
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.015
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.015
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.015
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.015
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.014
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.014
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.014
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.014
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.014
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.014
|
|
|
|
face development
|
GO:0060324 |
38 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.014
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.014
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.014
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.014
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.014
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.014
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.014
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.013
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.013
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.013
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.013
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.013
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.013
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.013
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.013
|
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.013
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.013
|
|
|
|
regulation of rna export from nucleus
|
GO:0046831 |
4 |
0.013
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.012
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.012
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.012
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.012
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.012
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.012
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
|
translation
|
GO:0006412 |
93 |
0.012
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.012
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.012
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.012
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.012
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.012
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.012
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.012
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.012
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.012
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.012
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.012
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.011
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.011
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.011
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.011
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.011
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.011
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.011
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.011
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.011
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.011
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.011
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.011
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.011
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.011
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.011
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.011
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.011
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.011
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.011
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.011
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.011
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.011
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.011
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.011
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.011
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.011
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.011
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.011
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.011
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.011
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.011
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.011
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.011
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.010
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.010
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.010
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.010
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.010
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.010
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.010
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.010
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.010
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.010
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.010
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.010
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.010
|
|
|
|
cdp choline pathway
|
GO:0006657 |
2 |
0.010
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.010
|
|